Research Topic · Peer-Reviewed

Hpv Vaccine

The HPV vaccine is a breakthrough in modern medicine that protects against infection from the Human Papillomavirus (HPV). HPV is the most common sexually transmitted infection and is a serious cause of cervical cancer in women, as well as other types of cancer in both men and women. The HPV vaccine works by stimulat…

Curated from this journal's research 📚 2 peer-reviewed articles cited Cited 1× across the literature 🔖 ISSN 2577-137X 🗓 Reviewed June 2026

Overview

The HPV vaccine is a breakthrough in modern medicine that protects against infection from the Human Papillomavirus (HPV). HPV is the most common sexually transmitted infection and is a serious cause of cervical cancer in women, as well as other types of cancer in both men and women. The HPV vaccine works by stimulating the body’s immune system to produce antibodies that provide protection against certain types of HPV. This vaccine has significantly reduced the risk of HPV infection, pre-cancerous lesions, and even cervical cancer. It is an important tool for protecting against sexually transmitted infections and some types of cancer and is recommended for both males and females, starting at age 9.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 2 articles above have been cited 1 time in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Hpv Vaccine, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Immunization (ISSN 2577-137X).

Journal editorial board
Giuseppe Murdaca · Italy Harunor Rashid · Australia Ming Tan · United States

This page summarises published research for orientation; it is not medical or professional advice.